Table 3.
Variables associated with infection complications.
| Univariate analysis | Multivariate analysis Intercept (SD) = 0.834 (0.82) | |||||||
|---|---|---|---|---|---|---|---|---|
| Variable | Infection | n (%) | Mean (SD) | Median (IQR) | Value of p | OR | 95%CI | Value of p |
| Age — years | 0.06080 | 2.17 | 0.65–3.69 | 0.0626 | ||||
| Yes | 46 (65.71) | 70.32 (7.58) | 71.5 (66.0–74.0) | |||||
| No | 24 (34.29) | 67.0 (12.48) | 66.0 (58.0–73.0) | |||||
| Leucocytes — x 109/L cells | 0.07511 | 0.78 | −3.71–5.27 | 0.868 | ||||
| Yes | 45 (64.29) | 8.35 (5.62) | 7.68 (4.73–10.4) | |||||
| No | 21 (30) | 10.82 (6.42) | 9.48 (5.0–14.9) | |||||
| Neutrophils — x 109/L cells | 0.03034 | 0.77 | −3,69–5.23 | 0.86 | ||||
| Yes | 44 (62.85) | 6.92 (5.36) | 5.525 (3.69–8.35) | |||||
| No | 20 (28.57) | 9.36 (5.26) | 8.09 (4.81–13.04) | |||||
| Hemoglobin — g/dL | 0.04004 | 1.04 | −0.65–2.73 | 0.9437 | ||||
| Yes | 45 (64.29) | 14.56 (5.60) | 14.5 (12.3–15.7) | |||||
| No | 22 (31.43) | 12.88 (2.53) | 13.05 (11.7–14.6) | |||||
| Albumin — g/dL* | 0.0709 | |||||||
| Yes | 19 (27.14) | 3.45 (0.59) | 3.37 (3.05–3.8) | |||||
| No | 6 (8.57) | 3.08 (0.39) | 3.1 (2.77–3.2) | |||||
| D-dimer — ng/mL* | 0.09222 | |||||||
| Yes | 37 (52.86) | 6873.5 (21344.1) | 1125.0 (704–2399) | |||||
| No | 16 (22.86) | 10222.1 (21946.3) | 1504.0 (1050.5–4229.5) | |||||
| Length of hospital stay — days | 0.001 | 2.39 | 0.87–3.91 | 0.036 | ||||
| Yes | 46 (65.71) | 30.78 (16.97) | 32.0 (17.5–40.5) | |||||
| No | 24 (34.29) | 16.95 (16.56) | 14.0 (1.75–25.25) | |||||
| Sex | 0.01430 | 0.49 | −1.9 to 2.88 | 0.4062 | ||||
| Yes | Men: 39 (84.78) | – | – | |||||
| Women: 7 (15.21) | ||||||||
| No | Men: 14 (58.33) | – | – | |||||
| Women: 10 (41.66) | ||||||||
| Obesity | 0.06255 | 0.61 | −1.81 to 3.03 | 0.5822 | ||||
| Yes | No: 38 (82.60) | - | - | |||||
| Yes: 8 (17.39) | ||||||||
| No | No: 15 (62.5) | - | - | |||||
| Yes: 9 (37.5) | ||||||||
| Mechanical ventilation | 0.0054 | 12.69 | 9.89–15,49 | 0.0137 | ||||
| Yes | Yes: 39 (84.78) | – | – | |||||
| No: 7 (15.21) | ||||||||
| No | Yes: 13 (54.16) | – | – | |||||
| No: 11 (45.83) | ||||||||
| Tocilizumab | 0.04470 | 1.50 | −0.87 to 3.87 | 0.6398 | ||||
| Yes | Yes: 25 (54.34) | – | – | |||||
| No: 21 (45.65) | ||||||||
| No | Yes: 7 (29.16) | – | – | |||||
| No: 17 (70.83) | ||||||||
Only variables with a value of p < 0.1 are included in the table.